Board of Directors
| Name | Main experiences (education background) |
|---|---|
| Andrew Lin Chairman | Education: MBA, University of Chicago Current Position: Chairman, BRIM Biotechnology, Inc. Chairman, NUWA Biomedical Inc. Independent Board Director, Fubon Life Insurance Company Limited Experience: Chairman, Lotus Pharmaceutical Co., Ltd. Managing Director of Greater China, Macquarie Capital Chief Financial Officer, LITE-ON GROUP General manager, JPMorgan Chase & Co. |
| Du-Shieng Chien Board Director | Education: Ph.D., College of Pharmacy, University of Iowa Current Position: President & CEO, TaiRx, Inc. Chairman, Efficient Pharma Management Corp. Chairman, Ascendo Biotechnology, Co., Inc. Experience: President & CEO, SunTen Phytotech Associate Director, Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes Director of DMPK, Neurogen Senior Staff Scientist, Bayer (Pharma Center, USA) Senior Scientist, Allergan, Inc. |
| Yi-Wen Chu Board Director | Education: Ph.D., Cancer Biology, University of Arizona Current Position: Senior Vice President, TaiRx, Inc. Board Director, Efficient Pharma Management Corp. Experience: President & CEO, Efficient Pharma Managment Corp. Vice President, SunTen Phytotech Associate Director of Intramural Research Affairs, National Health Research Institutes |
| Sheng-Chu Kuo Board Director | Education: Ph.D., Pharmacy, Meijo University Current Position: Chair Professor, China Medical University Experience: Principal, China Medical University Professor, School of Pharmacy, China Medical University Chairman, The Pharmaceutical Society of Taiwan |
| Tian-Shung Wu Board Director | Education: Ph.D., Pharmacy, Meijo University Current Position: Emeritus Professor, National Cheng-Kung University Experience: Chair of Department of Chemistry, National Cheng Kung University Director, National Research Institute of Chinese Medicine Dean of College of Pharmacy, China Medical University |
| Wen-Chyi Shyu Board Director | Education: Ph.D., Pharmacy, University of Connecticut Current Position: President & CEO, BRIM Biotechnology, Inc. Board Director, Ascendo Biotechnology, Co., Inc. Experience: Vice President, Head of Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical International Company Senior Director, Bristol-Myers Squibb Pharmaceutical Research |
| Yu-Kuan Lin Independent Board Director | Education: EMBA, National Chengchi University Current Position: Independent Board Director, intelliGo Techonology, Inc. Supervisor, Cuumed Catheter Medical Co., Ltd. Independent Board Director, Elite Semiconductor Microelectronics Technology Inc. Experience: CPA, PwC Taiwan |
| Chen-Wu Chang Independent Board Director | Education: MBA, University of Chicago Current Position: Independent Board Director, SyneuRx International (Taiwan) Corp. Independent Board Director, AnnJi Pharmaceutical Co., Ltd. Board Director, Anbogen Therapeutics, Inc. Experience: Senior Vice President, Ferring Pharmaceuticals Head, Asia Cluster, Novartis General Manager, Taiwan Novartis Managing Director, Johnson & Johnson, Taiwan |
| Chung-Chiang Chu Independent Board Director | Education: Master of Laws, London School of Economics and Political Science Experience: Head of Legal Affairs, Greater China,Pfizer Investment Co.,Ltd. Head of Legal Affairs, South Asia, Pfizer Pharmaceuticals Co., Ltd. Deputy General Manager of Legal Affairs, Pfizer Pharmaceuticals Co., Ltd. Lawyer, Tsar&Tsai Law Firm Adjunct Lecturer, Chinese Culture University, Department of Law |